Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 35.23B | 32.65B | 32.27B | 27.16B | 27.71B | 26.25B |
Gross Profit | 5.50B | 5.78B | 4.84B | 4.21B | 4.36B | 4.25B |
EBITDA | 3.05B | 2.96B | 2.57B | 2.11B | 2.26B | 2.00B |
Net Income | 1.99B | 1.79B | 1.59B | 1.28B | 1.37B | 1.18B |
Balance Sheet | ||||||
Total Assets | 27.19B | 30.29B | 33.22B | 29.12B | 27.19B | 26.05B |
Cash, Cash Equivalents and Short-Term Investments | 8.24B | 7.99B | 8.76B | 8.35B | 8.24B | 8.61B |
Total Debt | 1.08B | 566.15M | 1.02B | 1.01B | 1.08B | 1.05B |
Total Liabilities | 11.67B | 11.31B | 15.44B | 12.67B | 11.67B | 11.69B |
Stockholders Equity | 15.52B | 18.98B | 17.78B | 16.44B | 15.52B | 14.36B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 695.13M | 1.88B | 1.16B | 676.98M | 1.42B |
Operating Cash Flow | 0.00 | 1.13B | 1.98B | 1.32B | 965.19M | 1.58B |
Investing Cash Flow | 0.00 | -839.99M | -1.09B | -802.87M | -1.10B | -735.67M |
Financing Cash Flow | 0.00 | -1.11B | -486.81M | -446.03M | -263.17M | -197.73M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥14.64B | 8.71 | 3.11% | -2.16% | -8.63% | ||
78 Outperform | ¥13.60B | 7.62 | 4.71% | 1.16% | 12.22% | ||
76 Outperform | ¥13.44B | 7.70 | 4.56% | 33.76% | ― | ||
70 Neutral | ¥13.89B | 8.82 | 3.67% | 32.17% | 298.59% | ||
62 Neutral | ¥14.68B | 11.50 | 4.62% | 1.27% | -5.19% | ||
60 Neutral | ¥14.21B | 85.67 | 2.57% | -2.45% | -71.57% | ||
58 Neutral | $1.34B | 4.24 | -2.93% | 7.38% | 3.67% | -51.13% |